BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Groote KD, Prenen H. Intrahepatic therapy for liver-dominant metastatic colorectal cancer. World J Gastrointest Oncol 2015; 7(9): 148-152 [PMID: 26380058 DOI: 10.4251/wjgo.v7.i9.148]
URL: https://www.wjgnet.com/1948-5204/full/v7/i9/148.htm
Number Citing Articles
1
F. Y. Wang, W. Meng, Y. Li, T. Li, C. Y. Qin. Comparison of overall survival in patients with unresectable hepatic metastases with or without transarterial chemoembolization: A Propensity Score Matching StudyScientific Reports 2016; 6(1) doi: 10.1038/srep35336
2
Bert Hildebrandt, Bernhard Gebauer. Kompendium Internistische OnkologieSpringer Reference Medizin 2022; : 1 doi: 10.1007/978-3-662-46764-0_187-1
3
Yang Wang, Jiasheng Zheng, Hui Chen, Caixia Hu, Bin Sun, Haiyan Wang, Qinsheng Shi, Jiang Long, Honghai Zhang, Wei Li. A prognostic nomogram for colorectal cancer liver metastases after percutaneous thermal ablationInternational Journal of Hyperthermia 2018; 34(6): 853 doi: 10.1080/02656736.2017.1368095
4
Johannes M. Ludwig, Yongkang Gai, Lingyi Sun, Guangya Xiang, Dexing Zeng, Hyun S. Kim. SW43‐DOX ± loading onto drug‐eluting bead, a potential new targeted drug delivery platform for systemic and locoregional cancer treatment – An in vitro evaluationMolecular Oncology 2016; 10(7): 1133 doi: 10.1016/j.molonc.2016.05.003
5
Ana Wilson, Sean Ronnekliev-Kelly, Megan Winner, Timothy M. Pawlik. Liver-Directed Therapy in Metastatic Colorectal CancerCurrent Colorectal Cancer Reports 2016; 12(2): 67 doi: 10.1007/s11888-016-0311-z